. O1-10-03: an Active Anti-AB40 Vaccine (ABVAC40) Proved to be Safe and Immunogenic in the Phase i Clinical Trial. Alzheimer's & Dementia, 1 July 2016 Alzheimer's & Dementia

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

Therapeutics

  1. ABvac40